- All sections
- C - Chemistry; metallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/24 - Esteramides
Patent holdings for IPC class C07F 9/24
Total number of patents in this class: 357
10-year publication summary
29
|
32
|
29
|
33
|
33
|
26
|
17
|
22
|
28
|
8
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Gilead Sciences, Inc. | 1879 |
20 |
Cancer Targeted Technology LLC | 25 |
13 |
Sony Group Corporation | 10730 |
8 |
Sony Corporation | 32931 |
7 |
Suzhou Abogen Biosciences Co., Ltd. | 49 |
7 |
Medivir AB | 142 |
6 |
F. Hoffmann-La Roche AG | 7958 |
5 |
The Johns Hopkins University | 5377 |
5 |
Central Glass Company, Limited | 1244 |
5 |
Universite de Bretagne Occidentale | 112 |
5 |
UPL Limited | 524 |
5 |
LG Chem, Ltd. | 17205 |
4 |
Sony Corporation of America | 322 |
4 |
The Regents of the University of California | 18943 |
4 |
Centre National de La Recherche Scientifique | 9632 |
4 |
Chemapotheca, LLC | 13 |
4 |
Quiapeg Pharmaceuticals AB | 46 |
4 |
Washington State University | 449 |
4 |
Eisai R&D Management Co., Ltd. | 1304 |
4 |
Arysta LifeScience Inc. | 70 |
4 |
Other owners | 235 |